Additionally, future detailed validation of the PI3k/Akt and PGC-1α in myocarditis treatment by LC was not conducted in animal models to clarify their causal relationships in therapy, and the effects of other signaling pathways could not be entirely ruled out yet. The gene discussed is PPARGC1A; the disease is laryngotracheoesophageal cleft.